GlassScriptPhysician profile
Anna Lucia Bulla
NPI 1275971350
$1,804.07
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2021: $957 · 2022: $465 · 2023: $24.74 · 2024: $25.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $342.28 | 2021-2022 | |
| Abbvie INC. | $256.84 | 2021-2022 | |
| Lilly USA, LLC | $195.01 | 2021-2022 | |
| Novo Nordisk INC | $179.73 | 2019-2022 | |
| Amgen INC. | $145.83 | 2019-2022 | |
| Astellas Pharma US INC | $96.75 | 2021 | |
| Pfizer INC. | $86.41 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $82.23 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $68.66 | 2021 | |
| Amarin Pharma, INC. | $47.78 | 2019-2021 | |
| Glaxosmithkline, LLC. | $44.66 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $40.73 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $39.73 | 2019-2021 | |
| Horizon Therapeutics Plc | $32.79 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $30.33 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.68 | 2024 | |
| Genentech USA, INC. | $20.41 | 2019 | |
| Endo Pharmaceuticals INC. | $17.53 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.63 | 2022 | |
| Hikma Pharmaceuticals USA | $14.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.09 | 2021 | |
| Metacel Pharmaceuticals LLC | $8.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bulla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.